Admission to AIM

DawMed Systems PLC
14 October 2002


For Immediate Release:                                          14 October 2002



                    DAWMED SYSTEMS PLC STARTS TRADING ON AIM

DawMed Systems plc (DawMed), the medical devices company which designs,
manufactures, sells and services washer disinfectors used by NHS Trust
hospitals, private hospitals and clinics, has had its shares admitted to the
Alternative Investment Market (AIM) of the London Stock Exchange. It commences
trading today.

DawMed has arranged subscriptions for 1,000,000 new Ordinary Shares with private
investors at a price of 25p per share, raising £100,000 to cover the costs of
the Introduction to AIM and £150,000 of additional working capital for the
company.

Beaumont Cornish Limited continues to advise DawMed and is now Nominated
Adviser.  Hichens, Harrison & Co. plc is the company's Broker.

Kevin Gilmore, Chairman of DawMed, commented 'DawMed is delighted to begin
trading on AIM as it will help us to create both a wider market for our shares
and to raise our profile, facilitating DawMed's growth prospects.  It is a
particularly good time for us as we are soon to exhibit a design prototype of a
'bench-top' washer disinfector aimed at a new market of primary care
practitioners.'

For further information please contact:

Kevin Gilmore             Roland Cornish                Rosie Brown
Chairman                  Chairman                      Claire Melly
DawMed Systems plc        Beaumont Cornish Limited      Tavistock Communications
Tel: [phone]         Tel: [phone]            Tel: [phone]


The information contained in the press release is derived from and should be
read in conjunction with the full text of the prospectus dated 7 October 2002.


                      This information is provided by RNS
            The company news service from the London Stock Exchange